Parity and breast cancer in BRCA1/BRCA2 carriers

被引：2
|
作者：
Narod, S [1 ]
机构：
[1] Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada
来源：
LANCET | 2000年 / 356卷 / 9230期
关键词：
D O I：
10.1016/S0140-6736(05)73823-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：679 / 679
页数：1
相关论文
共 50 条
  • [1] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [2] Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
    Antoniou, Antonis C.
    Shenton, Andrew
    Maher, Eamonn R.
    Watson, Emma
    Woodward, Emma
    Lalloo, Fiona
    Easton, Douglas F.
    Evans, D. Gareth
    BREAST CANCER RESEARCH, 2006, 8 (06)
  • [3] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
  • [4] Radiotherapy of breast cancer in BRCA1 and BRCA2 carriers
    Marinko, T.
    Jerala, A.
    Krajc, M.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 59 - 59
  • [5] Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations
    Roukos, Dimitrios H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (15): : 1555 - 1556
  • [6] Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, K
    Lynch, HT
    Chadirian, P
    Tung, N
    Olivotto, V
    Warner, E
    Olopade, OI
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Foulkes, WD
    Narod, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2328 - 2335
  • [7] Breast cancer survival in carriers of BRCA1 and BRCA2 mutations
    Rennert, G.
    Bisland, S.
    Bar Joseph, N.
    Zhang, S.
    Rennert, H. S.
    Barnett-Griness, O.
    Narod, S. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Prognosis of BRCA1 and BRCA2 mutation carriers with breast cancer
    Rennert, G
    Bisland-Becktell, S
    Almog, R
    Zhang, S
    Rennert, HS
    Narod, S
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (02) : 221 - 221
  • [9] Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
    Warner, Ellen
    CANCERS, 2018, 10 (12)
  • [10] BRCA1 and BRCA2 in breast cancer
    Yang, XH
    Lippman, ME
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (01) : 1 - 10
12345